Orbimed-Advisors

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AKRO",
  "AXSM",
  "EWTX",
  "TRVI",
  "INSM",
  "FBRX",
  "KRYS",
  "ORIC",
  "TIL",
  "ARGX",
  "CBLL",
  "EXAS",
  "APLS",
  "ALNY",
  "ABCL",
  "FOLD",
  "ITGR",
  "BSX",
  "SWTX",
  null,
  "BCAX",
  "SLRN",
  "AVBP",
  "TNGX",
  "GPCR",
  "IMTX",
  "THRD",
  "TERN",
  "TYRA",
  "ACET",
  "ADCT",
  "KROS",
  "GILD",
  "ANRO",
  "AVTX",
  "AMLX",
  "JANX",
  "BIOA",
  "PHGE",
  "DHAI",
  "SRRK",
  "FATE",
  "ISRG",
  "TARS",
  "IVVD",
  "NBIX",
  "KRRO",
  "NXTC",
  "NKTX",
  "PMVP",
  "PRLD",
  "QTTB",
  "RPTX",
  "SIBN",
  "TSBX",
  "WHWK",
  "IONS",
  null,
  null,
  "UNH",
  "PFE",
  "SPRY",
  "AMGN",
  "SYK",
  "TMO",
  null,
  "UPB",
  "RAPT",
  "TRAW",
  "RNA",
  "AGIO",
  "MBX",
  "NPCE",
  "RYTM",
  "DYN",
  "SCPH",
  "PASG",
  null,
  "VRTX",
  "EW",
  "THC",
  "NTRA",
  null,
  null,
  "CRVS",
  "ELVN",
  "IKNA",
  null,
  "KZR",
  "VSTM",
  "VIR",
  "XERS",
  "XFOR",
  "XENE",
  "XTNT",
  "VERA",
  null,
  "CCCC",
  "CRDF",
  "CGON",
  "CMPX",
  "CRBP",
  "CRNX",
  "CGEM",
  "CYTK",
  "IRON",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 107
Total Value: 4035711615
Accession Number: 0001172661-25-002355
Form Type: 13F-HR
CIK: orbimed-advisors
Manager Name: Orbimed-Advisors

Data Enrichment

92% identified

98 identified9 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

107 positions • $4.0B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 6

Sort by:

CYTOKINETICS INC

CYTK|23282W605

Shares:1.5M

Value:$60.7M

% of Portfolio:1.5% ($60.7M/$4.0B)

CG Oncology, Inc.

CGON|156944100

Shares:2.5M

Value:$60.5M

% of Portfolio:1.5% ($60.5M/$4.0B)

ArriVent BioPharma, Inc.

AVBP|04272N102

Shares:3.0M

Value:$56.0M

% of Portfolio:1.4% ($56.0M/$4.0B)

Avidity Biosciences, Inc.

RNA|05370A108

Shares:1.8M

Value:$53.5M

% of Portfolio:1.3% ($53.5M/$4.0B)

SI-BONE, Inc.

SIBN|825704109

Shares:3.4M

Value:$48.3M

% of Portfolio:1.2% ($48.3M/$4.0B)

Axsome Therapeutics, Inc.

AXSM|05464T104

Shares:386.7K

Value:$45.1M

% of Portfolio:1.1% ($45.1M/$4.0B)

Compass Therapeutics, Inc.

CMPX|20454B104

Shares:22.4M

Value:$42.5M

% of Portfolio:1.1% ($42.5M/$4.0B)

NeuroPace Inc

NPCE|641288105

Shares:3.4M

Value:$41.9M

% of Portfolio:1.0% ($41.9M/$4.0B)

829401108

Shares:3.7M

Value:$38.8M

% of Portfolio:1.0% ($38.8M/$4.0B)

Upstream Bio, Inc.

UPB|91678A107

Shares:5.7M

Value:$34.8M

% of Portfolio:0.9% ($34.8M/$4.0B)

Xtant Medical Holdings, Inc.

XTNT|98420P308

Shares:73.1M

Value:$34.4M

% of Portfolio:0.9% ($34.4M/$4.0B)

Tarsus Pharmaceuticals, Inc.

TARS|87650L103

Shares:653.7K

Value:$33.6M

% of Portfolio:0.8% ($33.6M/$4.0B)

Crinetics Pharmaceuticals, Inc.

CRNX|22663K107

Shares:999.0K

Value:$33.5M

% of Portfolio:0.8% ($33.5M/$4.0B)

Xenon Pharmaceuticals Inc.

XENE|98420N105

Shares:947.9K

Value:$31.8M

% of Portfolio:0.8% ($31.8M/$4.0B)

Apellis Pharmaceuticals, Inc.

APLS|03753U106

Shares:1.4M

Value:$31.3M

% of Portfolio:0.8% ($31.3M/$4.0B)

MBX Biosciences, Inc.

MBX|55287L101

Shares:4.0M

Value:$29.5M

% of Portfolio:0.7% ($29.5M/$4.0B)

EXACT SCIENCES CORP

EXAS|30063P105

Shares:679.8K

Value:$29.4M

% of Portfolio:0.7% ($29.4M/$4.0B)

GILEAD SCIENCES, INC.

GILD|375558103

Shares:197.5K

Value:$22.1M

% of Portfolio:0.5% ($22.1M/$4.0B)

Corvus Pharmaceuticals, Inc.

CRVS|221015100

Shares:6.9M

Value:$22.1M

% of Portfolio:0.5% ($22.1M/$4.0B)

Terns Pharmaceuticals, Inc.

TERN|880881107

Shares:7.6M

Value:$20.9M

% of Portfolio:0.5% ($20.9M/$4.0B)

Instrument	Shares		Other Manager	Value	% of Portfolio
CYTOKINETICS INC(CYTKcusip23282W605)	1.5M	QoQ -4.72% (-74.8K) YoY +121.06% (+826.5K)	All Managers (Combined)	$60.7M	1.5% ($60.7M/$4.0B)	QoQ -18.59% (-$13.9M) YoY +26.72% (+$12.8M)
CG Oncology, Inc.(CGONcusip156944100)	2.5M	QoQ +72.73% (+1.0M) YoY NEW(+2.5M)	All Managers (Combined)	$60.5M	1.5% ($60.5M/$4.0B)	QoQ +47.49% (+$19.5M) YoY NEW(+$60.5M)
ArriVent BioPharma, Inc.(AVBPcusip04272N102)	3.0M	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$56.0M	1.4% ($56.0M/$4.0B)	QoQ -30.59% (-$24.7M) YoY +3.52% (+$1.9M)
Avidity Biosciences, Inc.(RNAcusip05370A108)	1.8M	QoQ +62.89% (+700.0K) YoY +82.36% (+818.8K)	All Managers (Combined)	$53.5M	1.3% ($53.5M/$4.0B)	QoQ +65.36% (+$21.2M) YoY +110.94% (+$28.1M)
SI-BONE, Inc.(SIBNcusip825704109)	3.4M	QoQ 0.00% (+0) YoY +8.45% (-268.3K)	All Managers (Combined)	$48.3M	1.2% ($48.3M/$4.0B)	QoQ +0.07% (+$34.4K) YoY -7.05% (-$3.7M)
Axsome Therapeutics, Inc.(AXSMcusip05464T104)	386.7K	QoQ NEW(+386.7K) YoY NEW(+386.7K)	All Managers (Combined)	$45.1M	1.1% ($45.1M/$4.0B)	QoQ NEW(+$45.1M) YoY NEW(+$45.1M)
Compass Therapeutics, Inc.(CMPXcusip20454B104)	22.4M	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$42.5M	1.1% ($42.5M/$4.0B)	QoQ +31.03% (+$10.1M) YoY -4.04% (-$1.8M)
NeuroPace Inc(NPCEcusip641288105)	3.4M	QoQ 0.00% (+0) YoY -14.92% (-597.6K)	All Managers (Combined)	$41.9M	1.0% ($41.9M/$4.0B)	QoQ +9.83% (+$3.7M) YoY -20.79% (-$11.0M)
(cusip829401108)✕	3.7M	QoQ NEW(+3.7M) YoY NEW(+3.7M)	All Managers (Combined)	$38.8M	1.0% ($38.8M/$4.0B)	QoQ NEW(+$38.8M) YoY NEW(+$38.8M)
Upstream Bio, Inc.(UPBcusip91678A107)	5.7M	QoQ 0.00% (-0) YoY NEW(+5.7M)	All Managers (Combined)	$34.8M	0.9% ($34.8M/$4.0B)	QoQ -62.77% (-$58.8M) YoY NEW(+$34.8M)
Xtant Medical Holdings, Inc.(XTNTcusip98420P308)	73.1M	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$34.4M	0.9% ($34.4M/$4.0B)	QoQ +6.09% (+$2.0M) YoY -59.82% (-$51.2M)
Tarsus Pharmaceuticals, Inc.(TARScusip87650L103)	653.7K	QoQ NEW(+653.7K) YoY NEW(+653.7K)	All Managers (Combined)	$33.6M	0.8% ($33.6M/$4.0B)	QoQ NEW(+$33.6M) YoY NEW(+$33.6M)
Crinetics Pharmaceuticals, Inc.(CRNXcusip22663K107)	999.0K	QoQ 0.00% (-0) YoY -27.87% (-386.0K)	All Managers (Combined)	$33.5M	0.8% ($33.5M/$4.0B)	QoQ -34.40% (-$17.6M) YoY -48.31% (-$31.3M)
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	947.9K	QoQ 0.00% (-0) YoY +72.34% (+397.9K)	All Managers (Combined)	$31.8M	0.8% ($31.8M/$4.0B)	QoQ -14.41% (-$5.4M) YoY +34.31% (+$8.1M)
Apellis Pharmaceuticals, Inc.(APLScusip03753U106)	1.4M	QoQ NEW(+1.4M) YoY +854.86% (+1.3M)	All Managers (Combined)	$31.3M	0.8% ($31.3M/$4.0B)	QoQ NEW(+$31.3M) YoY +255.27% (+$22.5M)
MBX Biosciences, Inc.(MBXcusip55287L101)	4.0M	QoQ +5.00% (-190.7K) YoY NEW(+4.0M)	All Managers (Combined)	$29.5M	0.7% ($29.5M/$4.0B)	QoQ -57.95% (-$40.7M) YoY NEW(+$29.5M)
EXACT SCIENCES CORP(EXAScusip30063P105)	679.8K	QoQ 0.00% (-0) YoY +384.19% (+539.4K)	All Managers (Combined)	$29.4M	0.7% ($29.4M/$4.0B)	QoQ -22.95% (-$8.8M) YoY +203.51% (+$19.7M)
GILEAD SCIENCES, INC.(GILDcusip375558103)	197.5K	QoQ -19.58% (-48.1K) YoY NEW(+197.5K)	All Managers (Combined)	$22.1M	0.5% ($22.1M/$4.0B)	QoQ -2.45% (-$556.2K) YoY NEW(+$22.1M)
Corvus Pharmaceuticals, Inc.(CRVScusip221015100)	6.9M	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$22.1M	0.5% ($22.1M/$4.0B)	QoQ -40.56% (-$15.1M) YoY +78.65% (+$9.7M)
Terns Pharmaceuticals, Inc.(TERNcusip880881107)	7.6M	QoQ 0.00% (-0) YoY -0.73% (-56.2K)	All Managers (Combined)	$20.9M	0.5% ($20.9M/$4.0B)	QoQ -50.18% (-$21.0M) YoY -58.23% (-$29.1M)